Covariate | OR | 95% CI based on robust SEs | p>|z| |
---|---|---|---|
Demographics | |||
Age | |||
6–34 | 1.533 | (0.689 to 3.409) | 0.295 |
35–44 | 3.484 | (1.935 to 6.271) | <0.001 |
45–54 | 1.562 | (0.867 to 2.817) | 0.138 |
55–64 | 1.476 | (0.834 to 2.613) | 0.181 |
65–74 | 1 | ||
75 or older | 0.960 | (0.513 to 1.798) | 0.899 |
Male (vs female) | 1.405 | (0.999 to 1.977) | 0.051 |
African-American (vs all other races) | 1.722 | (1.218 to 2.434) | 0.002 |
In-pt (vs ER encounter) | 0.704 | (0.477 to 1.038) | 0.077 |
Hospital or NH/LTC exposure within 90 days, or transferred from hospice | 2.299 | (1.608 to 3.286) | <0.001 |
Comorbid conditions | |||
Hypertension | 1.891 | (1.108 to 3.225) | 0.019 |
Delirium, dementia and amnestic and other cognitive disorders | 1.794 | (1.034 to 3.111) | 0.038 |
Obesity | 0.505 | (0.288 to 0.884) | 0.017 |
Acuity | |||
Respiratory failure, insufficiency, arrest (adult) | 2.369 | (0.971 to 5.780) | 0.058 |
Laboratory values | |||
Last blood glucose value recorded during encounter per 10 mg/dL | 1.025 | (1.009 to 1.041) | 0.002 |
ER, emergency room; in-pt, inpatient; LTC, long-term care exposure; NH, nursing home.